About SpaceOAR hydrogel
SpaceOAR hydrogel is a company based in Bedford (United States) founded in 2007 was acquired by Boston Scientific in October 2018. SpaceOAR hydrogel has raised $13.88 million across 3 funding rounds from investors including Boston Scientific. SpaceOAR hydrogel offers products and services including SpaceOAR Hydrogel. SpaceOAR hydrogel operates in a competitive market with competitors including BioProtect, Lucerno Dynamics, Quality Electrodynamics, m2m Imaging Corp and EXACT Therapeutics, among others.
- Headquarter Bedford, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Boston Scientific Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$13.88 M (USD)
in 3 rounds
-
Latest Funding Round
$10.88 M (USD), Series B
Jul 29, 2014
- Investors
-
Employee Count
Not available
-
Acquired by
Boston Scientific
(Oct 01, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SpaceOAR hydrogel
SpaceOAR hydrogel offers a comprehensive portfolio of products and services, including SpaceOAR Hydrogel.
Hydrogel spacer that protects rectum during prostate radiation therapy sessions.
Funding Insights of SpaceOAR hydrogel
SpaceOAR hydrogel has successfully raised a total of $13.88M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $10.88 million completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SpaceOAR hydrogel
SpaceOAR hydrogel has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Wide range of medical devices
|
Locked | Locked | Locked |
Investor details for SpaceOAR hydrogel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SpaceOAR hydrogel
Investment portfolio details for SpaceOAR hydrogel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SpaceOAR hydrogel
Detailed financials for SpaceOAR hydrogel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Spaceoar Hydrogel Comparisons
Peer comparison for SpaceOAR hydrogel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SpaceOAR hydrogel
SpaceOAR hydrogel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioProtect, Lucerno Dynamics, Quality Electrodynamics, m2m Imaging Corp. and EXACT Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Radiation protection technology is developed for prostate cancer radiotherapy.
|
|
| Locked | Locked | Locked |
Imaging technology for radiotracer quality assessment is developed.
|
|
| Locked | Locked | Locked |
Magnetic resonance equipment and accessories for clinical diagnosis
|
|
| Locked | Locked | Locked |
Preclinical MRI Imaging Devices and Accessories
|
|
| Locked | Locked | Locked |
Sonoporation platform is provided for diagnosing multiple diseases.
|
Detailed competitors of SpaceOAR hydrogel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Spaceoar Hydrogel
Complete news archive for SpaceOAR hydrogel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SpaceOAR hydrogel
SpaceOAR hydrogel was founded in 2007 and raised its 1st funding round 3 years after it was founded.
SpaceOAR hydrogel is headquartered in Bedford, United States.
John Pedersen is the current CEO of SpaceOAR hydrogel.
SpaceOAR hydrogel is a funded company, having raised a total of $13.88M across 3 funding rounds to date.
SpaceOAR hydrogel was established in 2007 in Bedford, United States, within the medical device sector focused on oncology. A hydrogel spacer is offered by the company to create separation between the prostate and rectum during radiation therapy procedures. This minimally invasive intervention is designed to minimize rectal injury risks. Operations center on the development and provision of this protective system for prostate cancer treatments.
SpaceOAR hydrogel's top competitors include BioProtect, EXACT Therapeutics and Quality Electrodynamics.
SpaceOAR hydrogel offers SpaceOAR Hydrogel.
SpaceOAR hydrogel has 1 investor. Key investors include Boston Scientific.